Here are some sample widgets you could interact with from this dashboard:
(1) Revenues expected to be in line with consensus estimates
Trefis estimates BSX's Q2 2021 revenues to be $2.94 Bil, in line with the consensus estimate of $2.94 Bil
Estimated Revenues - 2021Q2(E)
Trefis Estimates for Boston Scientific Revenues:
Expected Change (YoY): 46.8%
The chart to the right highlights trends in Boston Scientific's Revenues over the last four quarters along with our forecast for Q2 2021.
Quarterly Revenue Trend
(2) EPS likely to match consensus estimates
BSX's Q2 2021 earnings per share (EPS) expected to be $0.37 per Trefis analysis, matching the consensus estimate of $0.37
Estimated EPS- 2021Q2(E)
Trefis Estimates for Boston Scientific EPS:
Expected Change (YoY): -436.4%
The chart to the right highlights trends in BSX's EPS over the last four quarters along with our forecast for Q2 2021.
Quarterly EPS Trend
(3) Stock price estimate 12% higher than current market price
Trefis maintains a fair value of $49 for BSX's stock as opposed to the current market price of roughly $44.
BSX Stock Price
The Trefis Price Estimate for Boston Scientific stock represents the fair value for the company's stock over a one-year horizon.
Details about the chances of a rise in BSX stock in the near term can be found in a separate interactive dashboard.
The chart to the right highlights trends in BSX's stock price at the end of each of the last four quarters as well as the current stock price.
Stock Price (Quarter End)
#1. Estimating Boston Scientific's Total Revenues:
Boston Scientific's Revenues have seen a marginal increase of 0.9% from around $9.8 Bil in FY2018 to $9.9 Bil in FY2020 and we expect it to increase to $12 Bil in FY2021
A Separate Interactive Dashboard Analysis On Boston Scientific's Revenues Details How The Company Makes Money.
#2. Deriving Boston Scientific's Adjusted Net Income:
Boston Scientific's Adjusted Net Income has decreased from around $2.1 Bil in FY2018 to $1.4 Bil in FY2020 and we expect it to increase to $2.2 Bil in FY2021
This change is likely to be led by higher revenues and improved margins.
A Separate Interactive Dashboard Analysis On Boston Scientific's Margins Highlights The Company's Various Expenses Components In Detail.
Adjusted Net Income [AxB]
Adjusted Net Income Margin [A]
Total Revenue [B]
#3. Determining Boston Scientific's Adjusted EPS:
Boston Scientific's Adjusted EPS has decreased from $1.47 in FY2018 to $0.97 in FY2020 and we expect it to increase to $1.59 in FY2021
The change in EPS can be attributed to an increase in adjusted net income and a lower expected share count due to stock repurchases.
Adjusted EPS [A÷B]
Adjusted Net Income [A]
Shares Outstanding [B]
#4. Estimating Boston Scientific's Share Price:
Our Price Estimate of $49 For Boston Scientific's Stock is based on our Detailed Valuation Model, and implies a 30.8x P/E Multiple on expected FY2021 Adjusted EPS of $1.59
Trefis Price Estimate [AxB]
Adjusted EPS [A]
P/E Multiple [B]